Interventional technology provider C.R. Bard has signed an agreement to sell some of the assets of its endoscopic technologies division to medical technology firm ConMed for $80 million. The division, based in Billerica, MA, manufactures and markets devices and accessories used primarily by gastroenterologists for endoscopic procedures, according to Bard of Murray Hill, NJ.
The firm's enteral feeding and endoscopic suturing product lines were not included in the agreement and will be transferred to other Bard business units. Bard expects the transaction to close within 60 days.
By AuntMinnie.com staff writers
August 18, 2004
Related Reading
Bard ups Q1 forecast, March 10, 2004
Bard gets added clearance for vena cava filter, August 12, 2004
Ring takes over at Bard, August 8, 2003
Bard begins building new distribution site, July 31, 2003
Bard sales climb in Q2, July 17, 2003
Copyright © 2004 AuntMinnie.com
